Literature DB >> 12821516

Regional heterogeneity of cellular prion protein isoforms in the mouse brain.

Vincent Beringue1, Gary Mallinson, Maria Kaisar, Mourad Tayebi, Zahid Sattar, Graham Jackson, David Anstee, John Collinge, Simon Hawke.   

Abstract

Prion diseases are a group of invariably fatal neurodegenerative disorders that include Creutzfeldt-Jakob disease in humans, scrapie in sheep and goats, and bovine spongiform encephalopathy in cattle. The infectious agent or prion is largely composed of an abnormal isoform (PrPSc) of a host encoded normal cellular protein (PrPc). The conversion of PrPc to PrPSc is a dynamic process and, for reasons that are not clear, the distribution of spongiform change and PrPSc deposition varies among prion strains. An obvious explanation for this would be that the transformation efficiency in any given brain region depends on favourable interactions between conformations of PrPc and the prion strain being propagated within it. However, identification of specific PrPc conformations has until now been hampered by a lack of suitable panels of antibodies that discriminate PrPc subspecies under native conditions. In this study, we show that monoclonal antibodies raised against recombinant human prion protein folded into alpha or beta conformations exhibit striking heterogeneity in their specificity for truncations and glycoforms of mouse brain PrPc. We then show that some of these PrPc isoforms are expressed differentially in certain mouse brain regions. This suggests that variation in the expression of PrPc conformations in different brain regions may dictate the pattern of PrPSc deposition and vacuolation, characteristic for different prion strains.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12821516     DOI: 10.1093/brain/awg205

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  47 in total

Review 1.  Allosteric function and dysfunction of the prion protein.

Authors:  Rafael Linden; Yraima Cordeiro; Luis Mauricio T R Lima
Journal:  Cell Mol Life Sci       Date:  2011-10-09       Impact factor: 9.261

2.  PrPc does not mediate internalization of PrPSc but is required at an early stage for de novo prion infection of Rov cells.

Authors:  Sophie Paquet; Nathalie Daude; Marie-Pierre Courageot; Jérôme Chapuis; Hubert Laude; Didier Vilette
Journal:  J Virol       Date:  2007-07-11       Impact factor: 5.103

3.  Glycosylation-related genes are variably expressed depending on the differentiation state of a bioaminergic neuronal cell line: implication for the cellular prion protein.

Authors:  Myriam Ermonval; Daniel Petit; Aurélien Le Duc; Odile Kellermann; Paul-François Gallet
Journal:  Glycoconj J       Date:  2008-10-21       Impact factor: 2.916

4.  Atypical and classical forms of the disease-associated state of the prion protein exhibit distinct neuronal tropism, deposition patterns, and lesion profiles.

Authors:  Gabor G Kovacs; Natallia Makarava; Regina Savtchenko; Ilia V Baskakov
Journal:  Am J Pathol       Date:  2013-09-05       Impact factor: 4.307

5.  Selective amplification of classical and atypical prions using modified protein misfolding cyclic amplification.

Authors:  Natallia Makarava; Regina Savtchenko; Ilia V Baskakov
Journal:  J Biol Chem       Date:  2012-11-20       Impact factor: 5.157

6.  Prion protein glycosylation is not required for strain-specific neurotropism.

Authors:  Justin R Piro; Brent T Harris; Koren Nishina; Claudio Soto; Rodrigo Morales; Judy R Rees; Surachai Supattapone
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

7.  A camelid anti-PrP antibody abrogates PrP replication in prion-permissive neuroblastoma cell lines.

Authors:  Daryl Rhys Jones; William Alexander Taylor; Clive Bate; Monique David; Mourad Tayebi
Journal:  PLoS One       Date:  2010-03-22       Impact factor: 3.240

8.  Prnp knockdown in transgenic mice using RNA interference.

Authors:  Micaela Gallozzi; Jérome Chapuis; Fabienne Le Provost; Annick Le Dur; Caroline Morgenthaler; Coralie Peyre; Nathalie Daniel-Carlier; Eric Pailhoux; Marthe Vilotte; Bruno Passet; Laetitia Herzog; Vincent Beringue; José Costa; Philippe Tixador; Gaëlle Tilly; Hubert Laude; Jean-Luc Vilotte
Journal:  Transgenic Res       Date:  2008-03-19       Impact factor: 2.788

9.  Prion infection of epithelial Rov cells is a polarized event.

Authors:  Sophie Paquet; Elifsu Sabuncu; Jean-Louis Delaunay; Hubert Laude; Didier Vilette
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

10.  Species and strain glycosylation patterns of PrPSc.

Authors:  Konstantinos Xanthopoulos; Magdalini Polymenidou; Sue J Bellworthy; Sylvie L Benestad; Theodoros Sklaviadis
Journal:  PLoS One       Date:  2009-05-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.